SKA-31, a novel activator of SKCa and IKCa channels, increases coronary flow in male and female rat hearts

Cardiovascular Research

Volumn 97, Issue 2, 2013, Pages 339-348

  Mishra, Ramesh C ^a   Belke, Darrell ^a   Wulff, Heike ^b   Braun, Andrew P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ca2+ activated K+ channel; Coronary circulation; Endothelium; Vasodilation

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; ADENOSINE; BRADYKININ; CALCIUM CHANNEL STIMULATING AGENT; CARDIAC AGENT; NITROPRUSSIDE SODIUM; SKA 31; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ANIMALS; APAMIN; BENZOTHIAZOLES; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; MALE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SYSTOLE;

EID: 84872558798     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs326     Document Type: Article

References (49)

1. Busse R, Fleming I, Hecker M. Signal transduction in endothelium- dependent vasodilatation. Eur Heart J 1993;14(Suppl.1):2-9.
2. Busse R, Edwards G, Félétou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. TIPS 2002;23:374-380.
3. Grgic I, Kaistha A, Hoyer J, Köhler R. Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator responses-relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 2009;157:509-526.
4. Edwards G, Félétou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflügers Arch 2010;459:863-879.
5. Sheng J-Z, Braun AP. Small-and intermediate-conductance Ca2+-activated K+ channels directly control agonist-evoked nitric oxide synthesis in human vascular endothelial cells. Am J Physiol Cell Physiol 2007;293:C458-C467.
6. Stankevicius E, Lopez-Valverde V, Rivera L, Hughes AD, Mulvany MJ, Simonsen U. Combination of Ca2+-activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery. Br J Pharmacol 2006;149:560-572.
7. Crane GJ, Gallagher N, Dora KA, Garland CJ. Small-and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. J Physiol (Lond) 2003;553:183-189.
8. Doughty JM, Plane F, Langton PD. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to endothelium. Am J Physiol 1999; 276:H1107-H1112.
9. Eichler I, Wibawa J, Grgic I, Knorr A, Brakemeier S, Pries AR et al. Selective blockade of endothelial Ca2+-activated small-and intermediate- conductance K+ channels suppresses EDHF-mediated vasodilation. Br J Pharmacol 2003;138:594-601.
10. Hinton JM, Langton PD. Inhibition of EDHF by two new combinations of K+ channel inhibitors in rat isolated mesenteric arteries. Br J Pharmacol 2003;138:1031-1035.
11. Si H, Heyken WT, Wölfle SE, Tysiac M, Schubert R, Grgic I et al. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 2006;99:537-544.
12. Brahler S, Kaistha A, Schmidt VJ, Wölfle SE, Busch C, Kaistha BP et al. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 2009;119:2323-2332.
13. Köhler R, Hoyer J. The endothelium-derived hyperpolarizing factor: insights from genetic animal models. Kidney Int 2007;72:145-150.
14. Dalsgaard T, Kroigaard C, Misfeldt M, Simonsen U. Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles. Br J Pharmacol 2010;160:1496-1508.
15. Sheng J-Z, Ella S, Davis MJ, Hill MA, Braun AP. Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar dilation. FASEB J 2009;23:1138-1145.
16. Socha MJ, Behringer EJ, Segal SS. Calcium and electrical signalling along endothelium of the resistance vasculature. Basic Clin Pharmacol Toxicol 2011;110:80-86.
17. Félétou M. Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol 2009;156:545-562.
18. Dalsgaard T, Kroigaard C, Simonsen U. Calcium-activated potassium channels-a therapeutic target for modulating nitric oxide in cardiovascular disease? Expert Opin Ther Targets 2010;14:825-837.
19. Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J et al. Naphthol[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 2009;75:281-295.
20. Damkjaer M, Nielsen G, Bodendiek S, Staehr M, Gramsbergen JB, de Wit C et al. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. Br J Pharmacol 2012; 165:223-234.
21. Orshal JM, Khalil RA. Gender, sex hormones and vascular tone. Am J Physiol 2004; 286:R233-R249.
22. Ng MKC. New perspectives on Mars and Venus: Unravelling the role of androgens in gender differences in cardiovascular biology and disease. Heart Lung Circ 2007; 16:185-192.
23. Mombouli JV, Bissiriou I, Agboton V, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: a key mediator of the vasodilator action of bradykinin. Immunopharmacology 1996;33:46-50.
24. Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V. Modulators of small-and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 2007;14:1437-1457.
25. Burnham MP, Bychkov R, Félétou M, Richards GR, Vanhoutte PM, Weston AH et al. Characterization of an apamin-sensitive small-conductance Ca2+-activated K+ channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol 2002;135:1133-1143.
26. Bychkov R, Burnham MP, Richards GR, Edwards G, Weston AH, Félétou M et al. Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF. Br J Pharmacol 2002;137:1346-1354.
27. Neylon CB, Lang RJ, Fu Y, Bobik A, Reinhart PH. Molecular cloning and characterization of the intermediate-conductance Ca2+-activated K+ channel in vascular smooth muscle. Circ Res 1999;85:e33-e43.
28. Taylor MS, Bonev AD, Gross TP, Eckman DM, Brayden JE, Bond CT et al. Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res 2003;93:124-131.
29. Antonio A, Rocha e Silva M. Coronary vasodilation produced by bradykinin on isolated mammalian heart. Circ Res 1962;11:910-915.
30. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res 1980;47:807-813.
31. Harrison DG, Bates JN. The nitrovasodilators. New ideas about old drugs. Circulation 1993;87:1461-1467.
32. Paolocci N, Pagliaro P, Isoda T, Saavedra FW, Kass DA. Role of calcium-sensitive K+ channels and nitric oxide in in vivo coronary vasodilation from enhanced perfusion pulsatility. Circulation 2001;103:119-124.
33. Kurian MM, Berwick ZC, Tune JD. Contribution of IKCa channels to the control of coronary blood flow. Exp Biol Med 2011;236:621-627.
34. Schilling WP. Effect of membrane potential on cytosolic calcium of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 1989;257:H778-H784.
35. Yi FX, Zhang AY, Campbell WB, Zou AP, Van Breeman C, Li P-L. Simultaneous in situ monitoring of intracellular Ca2+ and NO in endothelium of coronary arteries. Am J Physiol 2002;283:H2725-H2732.
36. Mehrke G, Pohl U, Daut J. Effects of vasoactive peptides on the membrane potential of cultured bovine aortic and guinea-pig coronary endothelium. J Physiol (Lond) 1991; 439:277-299.
37. Ribeiro AS, Fernandes VS, Orensanz LM, Martinez MP, Recia P, Martinez-Saenz A et al. Mechanisms involved in the adenosine-induced vasorelaxation to the pig prostatic small arteries. Purinergic Signal 2011;7:413-425.
38. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Jugden D, Pearson JD et al. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 2002;16:1584-1594.
39. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 1997; 94:11651-11656.
40. Xu Y, Tuteja D, Zhang Z, Xu D, Zhang Y, Rodriguez J et al. Molecular identification and functional roles of a Ca2+-activated K+ channel in human and mouse hearts. J Biol Chem 2003;278:49085-49094.
41. Tuteja D, Xu D, Timofeyev V, Lu L, Sharma D, Zhang Z et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2 and SK3 in mouse atrial and ventricular myocytes. Am J Physiol Heart Circ Physiol 2005;289:H2714-H2723.
42. Li N, Timofeyev V, Tuteja D, Xu D, Lu L, Zhang Q et al. Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J Physiol (Lond) 2009;587:1087-1100.
43. Nagy N, Szuts V, Horvath Z, Seprenyi G, Farkas A, Acsai K et al. Does smallconductance calcium-activated potassium channel contribute to cardiac repolarization? J Mol Cell Cardiol 2009;47:656-663.
44. Diness JG, Sorensen US, Nissen JD, Al-Shahib B, Jespersen T, Grunnet M et al. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:380-390.
45. Diness JG, Skibsbye L, Jespersen T, Bartels ED, Sorensen US, Hansen RS et al. Effects on atrial fibrillation in aged hypertensive rats by Ca2+-activated K+ channel inhibition. Hypertension 2011;57:1129-1135.
46. Gregg DE. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res 1963;13:497-500.
47. Westerhof N, Boer C, Lamberts RR, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev 2006;86:1263-1308.
48. Lamberts RR, van Rijen MH, Sipkema P, Fransen P, Sys SU, Westerhof N. Coronary perfusion and muscle lengthening increase cardiac contraction: different stretch-triggered mechanisms. Am J Physiol Heart Circ Physiol 2002;283: H1515-H1522.
49. Iwamoto T, Bai XJ, Downey HF. Coronary perfusion related changes in myocardial contractile force and systolic ventricular stiffness. Cardiovasc Res 1994;28: 1331-1336.